Review Article





Merik Patel


ABSTRACT: Coronary heart disease (CHD) was a major problem in many developing countries during the twentieth century. Belarus is dealing with an increasing burden of noncommunicable diseases (NCDs), with coronary heart disease (CHD) now being the leading cause of death.  Despite a downward trend in Belarus' (CHD) mortality rates over the last decade, the country's all-cause mortality rate remains significantly higher than the European average. Scaling up population-based interventions is one of the main prospects for better prevention and regulation of (CHD) in Belarus. To address these issues, both at the population level and the level of individual programmes, action is required. Saturated fat (SFA), polyunsaturated fat (PUFA) al-6 (n-6) and trans-fat (TFA) all influence the risk of coronary heart disease (CHD), but there is no clear attributable mortality of coronary heart disease (CHD) by country, age, gender, or time period. Assume that the heart's beating capacity has been reduced to the point where the circulatory system is unable to adequately circulate blood. In that case, the lungs are more likely to swell with air, causing breathing difficulties. There may be a rapid increase in heart disease (acute heart failure) or a slow and steady increase (chronic heart failure). The goal of this study is to profile coronary heart disease in Belarus, as well as mortality rates and risk factors, to determine future directions for lowering death rates.

KEY WORDS: Coronary Heart Disease, Belarus, Cardiovascular Diseases, Noncommunicable Diseases.


  1. Noncommunicable diseases country profiles. Geneva: World Health Organizatio2014 ( publications/ncd-profiles-2014/en/).

  2. Institute of Health Metrics and Evaluation (IHME): Belarus 2017 (

  3.  Bahekar AA, Singh S, Saha S, Molnar J, Arora RJ. The prevalence and incidence of coronary heart disease is significantly increased in periodontitis a meta-analysis. J Gen Intern Med2007;154,5:830-837.

  4. Glushanko V, Shulmin A, Kugach V, Tarasova E, KhutkinaGA. Achievements, threats and risks of medical and pharmaceutical activities in the Republic of Belarus. J Gen Intern Med2020;3:11-19.

  5. Humphrey LL, Fu R, Buckley DI, Freeman M, Helfand MJ (2008). Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis.J Gen Intern Med 2007;23,12:2079.

  6.  Cobb FR, Kraus WE, Root M, Allen JD. Assessing risk for coronary heart disease: beyond Framingham. American Heart Journal 2003;146,4:572–580.

  7. Piepoli MF, Hoes AW, Agewall S. European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European journal of preventive cardiology 2016; 23,11:1-96.

  8. Bobak M, Malyutina S, Horvat P. Alcohol, drinking pattern and all-cause, cardiovascular and alcohol-related mortality in Eastern Europe. Eur J Epidemiol 2016; 31,1:21–30.

  9. Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J 2016;37,42:3232–3245.

  10. The Global Burden of Metabolic Risk Factors for Chronic Diseases C. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardio-metabolic risk factors between 1980 and 2010: Comparative risk assessment. The lancet Diabetes & endocrinology 2014;2,8:634–647.

  11. Stefler D, Bobak M. Does the consumption of fruits and vegetables differ between Eastern and Western European populations; Systematic review of cross-national studies. Archives of public health 2015;73,1:29–29.

  12. Murphy A, Johnson CO, Roth GA, et al. Ischaemic heart disease in the former Soviet Union 1990–2015 according to the Global Burden of Disease 2015 Study. Heart. 2018; 104(1): 58–66. DOI: 10.1136/heartjnl-2016-311142 

  13.  Leon DA, Shkolnikov VM, McKee M, Kiryanov N, Andreev E. Alcohol increases circulatory disease mortality in Russia: acute and chronic effects or misattribution of cause. International Journal of Epidemiology 2010;39,5):1279–1290.

  14. Labarthe DR. From cardiovascular disease to cardiovascular health: a quiet revolution. Circulation Cardiovascular quality and outcomes 2012;5,6:86–92.

  15. Lloyd-Jones DM, Hong Y, Labarthe D. Defining and setting national goals for cardiovascular health promotion and disease reduction.the American Heart Association’s strategic Impact Goal through 2020 and beyond Circulation 2010;121,4:586–613.

  16. Lopez-Jimenez F. The Pursuit of Ideal Cardiovascular Health: An Individual and Societal Challenge. Mayo Clinic Proceedings 2012;87,10:929–931.

  17. Maclagan LC, Tu JV. Using the concept of ideal cardiovascular health to measure population health: a review. Curr Opin Cardiol 2015;30,5:518–524.

  18. Kulesh SD, Kastsinevich TM, Kliatskova LA, Sauchanka ME, Filina NA, Shumskas MS. Long-term outcome after stroke in Belarus: the Grodno stroke study. Stroke 2011;42,11:3274-3276.

  19. LaatikainenT, CritchleyJ, VartiainenE, Salomaa V, KetonenM,  Capewell SJ. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am heart J2005;162,8:764-773.

 To cite this article:

Patel M. A study on belarus country's coronary heart diseases cases. Int. J. Med. Lab. Res. 2021; 6,2:55-60.